|
|
|
About Initiative
Accreditation Faculty Workshops Point of Care Webcast on Demand  Live webcast Outcomes Jointly sponsored by University of Kentucky College of Pharmacy and Vemco MedEd  This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC 
|
The online tutorial series with a case reinforces practical
application of tools and competencies acquired during the
live activity. Each tool is a combination of essentials in
clinical practice, links to relevant scientific publications, and
printable handout material for reference. Clinical Case
following the online tutorials gives the learners an opportunity
to earn extra CE credit upon completion.
What other changes would you consider for this patient? In addition to discontinuing tramadol and methadone due to concerns regarding QT interval prolongation, the clinician may consider weaning and eventually discontinuing cyclobenzaprine and carisoprodol as these may not be optimal choices for Emily's type of pain and can be contributing to adverse effects (such as memory loss). An SNRI (such as venlafaxine, milnacipran, or duloxetine) should be considered to treat fibromyalgia in addition to optimizing the dose of pregabalin. A controlled-release opioid can be used in place of methadone while topical diclofenac can be effective to treat knee and shoulder pain. This multimodal approach may offer Emily better results in alleviating her pain.5,6 Physical therapy and weight loss should also be encouraged to complement her pharmacotherapy program. The currently available long-acting oral opioid formulations are listed here:
Does Emily present with any risk factors for opioid abuse or misuse? |
Home About Us What We Do CME Portal Register for Programs Outcomes Reports Contact Us | Legal | Privacy Statement |